Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Products, net	$ 429,771	$ 309,322	$ 1,149,803	$ 779,805
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Collaboration and other	$ 37,401	$ 22,495	$ 93,764	$ 66,750
Total revenues	467,172	331,817	1,243,567	846,555
Cost and expenses:
Cost of sales (excluding amortization of in-licensed rights)	91,691	37,026	186,795	106,167
Research and development	224,483	194,301	604,569	681,870
Selling, general and administrative	128,200	120,893	393,999	350,171
Amortization of in-licensed rights	602	439	1,804	796
Total cost and expenses	444,976	352,659	1,187,167	1,139,004
Operating (loss) income	22,196	(20,842)	56,400	(292,449)
Other income (loss), net:
Other income (expense), net	11,810	(12,332)	32,631	17,309
Gain from sale of Priority Review Voucher	0	0	0	102,000
Loss on debt extinguishment	0	0	0	(387,329)
Total other income (loss), net	11,810	(12,332)	32,631	(268,020)
Income (loss) before income tax expense	34,006	(33,174)	89,031	(560,469)
Income tax expense	395	7,763	12,841	21,163
Net income (loss)	33,611	(40,937)	76,190	(581,632)
Other comprehensive income:
Unrealized gains on investments, net of tax	3,275	417	1,327	1,026
Total other comprehensive income	3,275	417	1,327	1,026
Comprehensive income (loss)	$ 36,886	$ (40,520)	$ 77,517	$ (580,606)
Earnings (loss) per share:
Basic	$ 0.35	$ (0.46)	$ 0.8	$ (6.56)
Diluted	$ 0.34	$ (0.46)	$ 0.78	$ (6.56)
Weighted average number of shares of common stock used in computing earnings (loss) per share:
Basic	95,390	88,889	94,669	88,609
Diluted	100,448	88,889	99,572	88,609